Overview

Effectiveness of Two Protocols for Corporal Decolonization in Patients Colonized by Methicillin Resistant Staphylococcus Aureus (MRSA)

Status:
Terminated

Trial end date:
2011-12-01

Target enrollment:

Participant gender:

Summary

Multicenter Clinical Trial, experimental, randomized and prospective study to determine the effectiveness of two protocols addressing the Corporal Decolonization in patients colonized by Methicillin Resistant Staphylococcus Aureus (MRSA). PRIMARY END POINT The aim of this trial is to evaluate the effectiveness of the protocol Prontoderm® in the decolonization of MRSA patients, compared with the protocol of the "Consensus Document and GEIH-SEIMC SEMPSPH" (see attached extract from the document, Annex 7). Prontoderm ® is a Class III Medical Device with CE mark owned by B.BRAUN Medical SA, and currently available in Spain for the same indications proposed in this trial.

Phase:

Phase 4

Details

Lead Sponsor:

B. Braun Medical SA

Treatments:

Anti-Bacterial Agents
Antibiotics, Antitubercular
Chlorhexidine
Chlorhexidine gluconate
Methicillin
Mupirocin